Kraig Biocraft Laboratories secures new investment license allowing for further production scale-up

The newly acquired investment license empowers Kraig Labs to scale its production operations significantly and begin addressing the growing requests for materials and requests for quote that it has been fielding. This expansion will bolster the Company’s ability to provide its innovative materials to a broad spectrum of markets, including textiles, defense, and medical sectors, eagerly anticipating these breakthrough fibers’ commercial availability.

“We are thrilled to secure this new investment license in Vietnam. This license is a testament to our commitment to expanding our production capabilities and the confidence the team placed in our technology,” said Founder and CEO of Kraig Labs, Kim Thompson. “This license positions us to grow our production footprint and fulfill the increasing demand for materials. This expansion is moving us forward with our vision for cost-effective spider silk production become a reality.”

The Company’s expansion plans in Vietnam include developing advanced rearing facilities and increasing the production of its advanced materials. The Company remains committed to environmentally sustainable practices, leveraging its biotech innovations to deliver materials that are strong, lightweight, and eco-friendly.

This development aligns with Kraig Labs’ vision to revolutionize material science by bringing to market one of the most sought-after and impactful biomaterials of the 21st century.

For details about other recent advancements the Company has made, please see the Company’s investor conference at www.kraiglabs.com/videos or through the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news